Alterations in the PIK3CA pathway are common in HNSCC, and studies have linked PIK3CA mutations to poorer survival in patients with head and neck cancer [23], as well as other solid tumors [24]. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.